DavidsonX: Measuring Pharmacodynamics: From Ligand Binding to Clinical Outcomes

0
Last updated on June 14, 2026 4:36 am
Add your review

Drugs are biologically active compounds. Drug discovery and drug development rely on methods for measuring biological activity. The term “activity” is quite general. In practice, a substance’s biological activity can refer to how a substance affects a biological pathway, cell-level responses, safety risks, how long a substance resides within in a system, as well as a substance’s effects in an organism (called pharmacodynamics). The design of methods for measuring activity is a critical aspect of drug discovery. The design of robust and informative methods can accelerate the drug discovery and development process.

User Reviews

0.0 out of 5
0
0
0
0
0
Write a review

There are no reviews yet.

Be the first to review “DavidsonX: Measuring Pharmacodynamics: From Ligand Binding to Clinical Outcomes”

×

    Your Email (required)

    Report this page
    DavidsonX: Measuring Pharmacodynamics: From Ligand Binding to Clinical Outcomes
    DavidsonX: Measuring Pharmacodynamics: From Ligand Binding to Clinical Outcomes
    LiveTalent.org
    Logo